You are here: Industry Insights > Market News > Natco Pharma board okays acquiring 1 per cent in Canadian arm

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Natco Pharma board okays acquiring 1 per cent in Canadian arm

expresspharmaMarch 29, 2021

Tag: Natco Pharma , Natco Pharma Ltd , acquisition

Favorites

Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary .

The company, however, did not disclose the value of the deal.

‘The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada), after this acquisition Natco Pharma (Canada) Inc., (will) become a wholly owned subsidiary company of Natco Pharma Ltd,’ Hyderabad-based Natco Pharma said in a regulatory filing.

The company did not share any more details.

Previous:SCHOTT reaches COVID-19 milestone: vials for one bn vaccine doses delivered

Next:Biocon Pharma joins hands with Libbs Farmaceutica to launch generic medicines in Brazil

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Natco Pharma board okays acquiring 1 per cent in Canadian arm | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

Natco Pharma board okays acquiring 1 per cent in Canadian arm

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Natco Pharma board okays acquiring 1 per cent in Canadian arm

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>